학술논문

The progress of clinical research on the detection of 1,5-anhydroglucitol in diabetes and its complications
Document Type
article
Source
Frontiers in Endocrinology, Vol 15 (2024)
Subject
blood glucose monitoring
diabetes
screen for diabetes
diabetes management
diabetes complications
1,5-Anhydroglucitol
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
Language
English
ISSN
1664-2392
Abstract
1,5-Anhydroglucitol (1,5-AG) is sensitive to short-term glucose fluctuations and postprandial hyperglycemia, which has great potential in the clinical application of diabetes as a nontraditional blood glucose monitoring indicator. A large number of studies have found that 1,5-AG can be used to screen for diabetes, manage diabetes, and predict the perils of diabetes complications (diabetic nephropathy, diabetic cardiovascular disease, diabetic retinopathy, diabetic pregnancy complications, diabetic peripheral neuropathy, etc.). Additionally, 1,5-AG and β cells are also associated with each other. As a noninvasive blood glucose monitoring indicator, salivary 1,5-AG has much more benefit for clinical application; however, it cannot be ignored that its detection methods are not perfect. Thus, a considerable stack of research is still needed to establish an accurate and simple enzyme assay for the detection of salivary 1,5-AG. More clinical studies will also be required in the future to confirm the normal reference range of 1,5-AG and its role in diabetes complications to further enhance the blood glucose monitoring system for diabetes.